Efficacy and Safety of Mildronate for Acute Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

Also called NCT01800357

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01800357
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01800357. Randomized; quadruple masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Mildronate for Acute Ischemic Stroke
Condition
Acute Ischemic Stroke
Intervention (Drug)
infusion of mildronate
Intervention (Drug)
placebo
Intervention (Drug)
aspirin
Lead sponsor
Xijing Hospital (class: other)

Record details

Record id
cardio:ct-nct01800357
Content hash
4e1846d5165bc77fea129141f3e41fb42b09a12d389d3a9ce105c486fa19c510